These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3709770)

  • 41. Use of chemically-bonded cyclodextrin stationary phase for high performance liquid chromatographic determination of feldene capsules.
    Ahmed AN; el-Gizawy SM
    J Chromatogr Sci; 1987 Sep; 25(9):424-6. PubMed ID: 3667839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Stabilization of chlorobutanol with beta-cyclodextrin in suppositories].
    Gyulai M; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):125-8. PubMed ID: 3739724
    [No Abstract]   [Full Text] [Related]  

  • 43. Application of freezing point depression to drug interaction studies. I. Interaction between cyclodextrins and alcohols.
    Suzuki M; Ueda S; Kusai A
    Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):720-5. PubMed ID: 3409380
    [No Abstract]   [Full Text] [Related]  

  • 44. Amorphous water-soluble cyclodextrin derivatives: 2-hydroxyethyl, 3-hydroxypropyl, 2-hydroxyisobutyl, and carboxamidomethyl derivatives of beta-cyclodextrin.
    Irie T; Fukunaga K; Yoshida A; Uekama K; Fales HM; Pitha J
    Pharm Res; 1988 Nov; 5(11):713-7. PubMed ID: 3247276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dissolution behavior of prednisolone from solid dispersion systems with cyclodextrins and polyvinylpyrrolidone.
    Fukuda N; Higuchi N; Ohno M; Kenmochi H; Sekikawa H; Takada M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1366-9. PubMed ID: 3731351
    [No Abstract]   [Full Text] [Related]  

  • 46. Spectral displacement techniques for studying the binding of spectroscopically transparent ligands to cyclodextrins.
    Selvidge LA; Eftink MR
    Anal Biochem; 1986 May; 154(2):400-8. PubMed ID: 3755301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereochemistry of circularly closed oligosaccharides: cyclodextrin structure and function.
    Saenger W
    Biochem Soc Trans; 1983 Apr; 11(2):136-9. PubMed ID: 6662270
    [No Abstract]   [Full Text] [Related]  

  • 48. Determination of cyclodextrins in biological fluids by high-performance liquid chromatography with negative colorimetric detection using post-column complexation with phenolphthalein.
    Frijlink HW; Visser J; Drenth BF
    J Chromatogr; 1987 Apr; 415(2):325-33. PubMed ID: 3584371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclodextrin-stabilized volatile substances for inhalation therapy.
    Gál-Füzy M; Szente L; Szejtli J; Harangi J
    Pharmazie; 1984 Aug; 39(8):558-9. PubMed ID: 6504980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients.
    Pitha J; Pitha J
    J Pharm Sci; 1985 Sep; 74(9):987-90. PubMed ID: 4067854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Encapsulation of nutraceutical monoterpenes in beta-cyclodextrin and modified starch.
    Mourtzinos I; Kalogeropoulos N; Papadakis SE; Konstantinou K; Karathanos VT
    J Food Sci; 2008 Jan; 73(1):S89-94. PubMed ID: 18211376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state.
    Uekama K; Sakai A; Arimori K; Otagiri M; Saitô H
    Pharm Acta Helv; 1985; 60(4):117-21. PubMed ID: 4011623
    [No Abstract]   [Full Text] [Related]  

  • 53. Cyclodextrins: a new group of industrial basic materials.
    Szejtli J
    Nahrung; 1985; 29(9):911-24. PubMed ID: 4079975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wettability of cyclodextrin complexes.
    Szente L; Szejtli J
    Acta Pharm Hung; 1987 Mar; 57(1-2):73-6. PubMed ID: 3591344
    [No Abstract]   [Full Text] [Related]  

  • 55. Epimerization and racemization of some chiral drugs in the presence of cyclodextrin and liposomes.
    Aso Y; Yoshioka S; Takeda Y
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2786-9. PubMed ID: 2611938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microcalorimetric investigations of pharmaceutical complexes. I. Drugs and beta-cyclodextrin.
    Hardee GE; Otagiri M; Perrin JH
    Acta Pharm Suec; 1978; 15(3):188-99. PubMed ID: 716952
    [No Abstract]   [Full Text] [Related]  

  • 57. Suppositories containing cyclodextrin complexes. Part 2: Dissolution and absorption studies.
    Szente L; Apostol I; Gerlóczy A; Szejtli J
    Pharmazie; 1985 Jun; 40(6):406-7. PubMed ID: 4034649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of a sulfamethoxazole-beta-cyclodextrin complex in suppositories].
    Tóth K; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):133-7. PubMed ID: 3739726
    [No Abstract]   [Full Text] [Related]  

  • 59. [Molecular cavity filling and tabletting with beta-cyclodextrin].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643
    [No Abstract]   [Full Text] [Related]  

  • 60. Planar chromatographic separation of enantiomers and diastereomers with cyclodextrin mobile phase additives.
    Armstrong DW; He FY; Han SM
    J Chromatogr; 1988 Sep; 448(3):345-54. PubMed ID: 3243840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.